Abbreviations used: [Ca2+]i ' cytosolic [Ca 2 +]; PAR, proteolytically activated receptor; RBCE, rat brain capillary endothelial.
Summary: Both thrombin and plasmin induce contraction of brain endothelial cells, which may increase capillary perme ability thereby leading to disruption of the blood-brain barrier. Identification of thrombin receptors, as well as the influence of plasmin on their activation, in capillary endothelial cells and astrocytes are therefore essential for understanding injury related actions of thrombin in the brain. Using the reverse transcriptase-polymerase chain reaction method, the present study shows that primary cultures of rat brain capillary endo thelial (RBCE) cells and astrocytes derived from rat brain ex press two different thrombin receptors. The first is proteolyti cally activated receptor (PAR)-l, the receptor responsible for the vast majority of the thrombin's cellular activation func tions; the second is PAR-3, a receptor described to be essential for normal responsiveness to thrombin in mouse platelets. In addition to these thrombin receptors, the mRNA (messenger RNA) for PAR-2, a possible trypsin receptor, was also identi fied. Functional significance of thrombin receptors was indi cated by changes in rCa 2 +l; in response to thrombin, as mea sured by FURA-2 fluorescence in RBCE cells. Thrombin as low as 4 nmollL induced an abrupt increase in lCa 2 +1i whereas, Thrombosis is of paramount importance in the patho physiology of ischemic stroke. Thrombogenic and fibri nolytic enzymes accumulating in the occluded vascular segments may play a role in the opening of the blood brain barrier, and the subsequent exposure of cells in the brain to high amounts of thrombin and plasmin is likely to have deleterious effects. Thrombin actions are largely mediated by PAR-I, the first member of the proteolyti-upon addition of active site-blocked thrombin or plasmin, [Ca 2 +1i remained unchanged. The [Ca 2 +l; signal attributable to thrombin was smaller in a low Ca 2 +-containing medium, indi cating that an int1ux of Ca 2 + from the extracellular medium makes a contribution to the overall [Ca 2 +l; rise. The amplitude of the transient [Ca 2 +l; signal was dependent on the concentra tion of thrombin, and repeated application of the enzyme caused an essentially complete and long-term desensitization of the receptor. The PAR-I agonist peptide SFLLRN also elicited a transient increase in [Ca 2 +l;. After activation by SFLLRN, cells showed a diminished response to thrombin, but the re sponse was not absent, indicating that PAR-3 might contribute to the generation of the [Ca 2 +1i signal. Pretreatment of RBCE cells with 100 nmol/L plasmin completely prevented [Ca 2 +l; rise attributable to thrombin. These data show that RBCE cells and astrocytes express at least two receptors for thrombin, PAR-I and PAR-3, and probably both receptors are involved in thrombin-induced [Ca 2 +li signals. Plasmin itself does not el evate [Ca 2 +l; but prevents the activation of receptors by throm bin. Key Words: PAR-Thrombin-Plasmin-Brain capillary endothelial cells-Astrocytes-Intracellular calcium.
cally activated G-protein-coupled receptor family to be discovered (Vu et al., 1991; Rasmussen et al., 1991) . The N-terminus of this receptor is cleaved by thrombin be tween residues Arg 41 and Ser 42 , exposing a new N terminus whose first five residues serve as a tethered ligand initiating the receptor activation. Accordingly, synthetic peptides comprising the amino terminus of the cleaved receptor, such as SFLLRN, can mimic the ef fects of thrombin. Thrombin receptors homologous to those on platelets have also been identified on fibroblasts (Rasmussen et aI., 1991; Coughlin et al., 1992) , endo thelial cells (Vu et al., 1991; Bartha et aI., 1993; Molino et al., 1995) , smooth muscle cells (Zhong et al., 1992) , and macrophages .
PAR-l mRNA (messenger RNA) is expressed in high levels in the nervous system (Soifer et al., 1994; Suidan et al., 1996) , in neuronal, glial, and ependymal cells (Weinstein et al., 1995) . Thrombin can affect a number of functions in the brain; it causes neurit retraction (Gur witz and Cunningham, 1988) , stimulates proliferation in astrocytes (Perraud et aI., 1987) , and increases the ex pression of nerve growth factor in glial cells (Neveu et aI., 1993) . In rat C6 glioma cells thrombin provokes [Ca 2 +] signals (Tas and Koschel, 1990) . A strong de crease in thrombin receptor expression occurs in most parts of the brain between the second and third postnatal week (Niclou et aI., 1994) , suggesting that the receptor may be important for development (Risau and Wolburg, 1990) . Additional circumstantial evidence supporting the importance of thrombin receptors in the brain comes from studies demonstrating the expression of prothrom bin mRNA (Dihanich et aI., 1991 ), its regional codistri bution with PAR-I (Soifer et aI., 1994) , and the presence of the thrombin inhibitor protease nexin around cerebral blood vessels where the inhibitor could protect neural tissue from extravasated thrombin (Choi et a!., 1990) .
Endothelial cells of brain capillaries are the site of the blood-brain barrier, which guarantees brain homeostasis by preventing free diffusion of molecules into the brain (Pardridge, 1991) . Intimately associated with endothelial cells, astrocytes are believed to participate in the blood brain barrier function; they contribute to tight junction formation (Janzer and Raff, 1987) . In addition, astrocytes provide a trophic support for neuronal growth and dif ferentiation (Vernadakis, 1988) . In astrocytes effects of thrombin have been shown to be mediated by PAR-l (Pike et aI., 1996) , but data on thrombin receptor mRNA as well as on thrombin-induced alterations in brain cap illary endothelial cells are contradictory; in fact the pres ence of functional thrombin receptors in these cells has not yet been demonstrated. Although it has been reported that PAR-l mRNA is widely expressed in embryonic mouse brain capillary endothelial cells (Soifer et a!., 1994) , in situ hybridization studies have failed to show the presence of PAR-l mRNA in the cerebrovascular endothelium derived from adult rat brain (Weinstein et aI., 1995) . Apparently inconsistent with the latter find ing, thrombin causes shape changes (Nagy et a!., 1995) and stimulates urokinase production and DNA synthesis (Shatos et aI., 1995) in cultured human brain capillary endothelial cells. It is possible that thrombin receptors different from PAR -I are responsible for these cellular effects, since recent studies have provided evidence for the existence of a more extended gene family of PAR-s displaying similar mechanism of activation. PAR-2 is known to be activated by trypsin and tryptase but not by thrombin (Nystedt et aI., 1995) . In addition to responding to peptide agonists based upon its own tethered ligand domain, PAR-2 can also be activated by the PAR-l ago nist peptide SFLLRN (Molino et aI., 1997) . In mouse and rat platelets another thrombin receptor, PAR-3, is neces sary for normal thrombin responses (Ishihara et aI., 1997) , whereas PAR-l plays no apparent role (Connolly J Cereb Blood Flow Metab, Vol. 20, No. 1. 2000 et aI., 1994 . Furthermore, besides PAR-3, a PAR-4mediated mechanism for thrombin signaling has also been demonstrated in these cells (Kahn et aI., 1998) .
Any protease can be an agonist on protease-activated receptors which cleave the N-terminus at the site re quired for the exposure of the tethered ligand domain. Plasmin can bind with high affinity to endothelial cells (Bauer et a!., 1984; Hall et aI., 1991) , eliciting functional responses through a specific plasmin receptor, but by cleaving at Arg 41 _Ser 42 it also has the potential to acti vate PAR-I (Parry et a!., 1996) . Plasmin is known to affect platelet activation; at high concentrations it in creases, but at lower concentrations it inhibits thrombin induced platelet activation (Kimura et aI., 1996; Kin lough-Rathbone et aI., 1997) . Plasmin also modulates the thrombin-evoked calcium response in C6 glioma cells (Turner et aI., 1994) . Recently we have shown that not only thrombin but also plasmin can induce the contrac tion of human brain capillary endothelial cells in culture (Nagy et aI., 1995) . Because thrombin receptors have not yet been identified in brain capillary endothelial cells, the present study aims to show the expression of the recep tors in primary cultures of these cells derived from rat brain and to compare them with the receptors present on astrocytes. In order to demonstrate functional responses of the cells, we measured the changes in [Ca 2 +]i after stimulation with thrombin or the P AR-l agonist peptide SFLLRN and examined the modification of the throm bin-induced changes in [Ca 2 +1 by plasmin.
METHODS

Preparation of rat brain capillary endothelial cells
Endothelial cells were obtained from brain capillary frag ments using a method described earlier (Domoti.ir et aI., 1998) . Shortly, the gray matter of the brain from 3-to 5-month-old Lewis rats was chopped into 2-to 3-mm pieces, homogenized, and centrifuged to separate capillary fragments. The capillary pellet was digested for 3 hours in a 0.1 % collagenase/dispase (Boehringer-Mannheim, Germany) solution, and the digested suspension was centrifuged on a Percoll (Pharmacia, Uppsala, Sweden) density gradient. The isolated capillary fragments were plated on extracellular matrix-coated glass coverslips which were prepared as described previously (Domoti.ir et aI., 1998) .
Brain endothelial cell cultures plated on extracellular matrix were kept in DMEM containing 17% plasma-derived bovine serum (Sigma), supplemented with 2 mmollL glutamin, 80 f,Lg/ mL heparin, 150 f,Lg/mL endothelial cell growth supplement (Sigma, St. Louis, MO, U.S.A.), antibiotics, and trace factors (vitamin C, selenium, insulin, transferrin, and glutathione).
To obtain pure endothelial cultures, cells were exposed to anti-Thy l.l-complement killing procedure (Domoti.ir et aI., 1998). On the second day after seeding, cells were incubated with monoclonal anti-Thy 1.1 antibody (Sigma, 1:500 dilution in serum-free medium) for 40 minutes at 37°C. After washing, rabbit complement (Sigma, dilution 5:3 in serum-free medium) was added for a maximum of 120 minutes at 37°C in order to lyse pericytes and astrocytes. After washing, the cells were normally fed with serum-containing medium. Cell cultures be-came confluent after 7 to 10 days. Only primary cultures were used for the experiments.
Preparation of primary astrocyte culture
Astrocyte culture was prepared from forebrain of I-day-old rats as described by Madanlsz et al. (1991) .
Immunocytochemistry
Von-Willebrand antigen was detected on cells permeabilized with 0.4% paraformaldehyde and Triton X-100. Cells were incubated with rabbit anti-human Von-Willebrand factor anti body (factor VIII-related antigen, Dako), and this was followed by incubation with biotinilated anti-rabbit IgG and the strepta vidin-peroxidase complex (Dako, Glostrup, Dania).
Measurement of [Ca 2 +]; in single cells
[Ca 2 +li was measured as detailed elsewhere (DbmbtOf et a!., 1999). Endothelial cells plated on extracellular matrix-coated coverslips were loaded with Fura-2 acetoxymethyl ester (Sigma) for 1 hour at 37°C in culture medium, followed by the transfer of the coverslips into a preformed perfusion chamber fitted to the stage of an inverted microscope. The perfusion chamber was prewarmed to 3TC, and the cells were superfused with a Hepes buffer of the following composition (in mmolfL): 141.6 NaCI, 5.4 KCI, 1.6 MgCI 2 , 2 CaCI2, II glucose, 20 Hepes, pH 7.4, at a rate of 2 mLimin for at least 10 minutes before the experiments. Agonists were introduced using a very fine perfusion system; the diameter of the input tip was con structed to be approximately 60 to 100 fLm and was adjusted before the experiments to the close vicinity of the particular cell with a micromanipulator under microscope control.
Excitation wavelengths were 343 and 376 nm (bandwidth, 10 nm). Fluorescence ratio of F343 over F376 was monitored using a PTI PatioMaster System equipped with Felix for Windows Softwares, and converted to free [Ca 2 +li by the equation of Grynkiewicz et al. (1985) using an in vitro calibration method and a correction for the viscosity (Poenie, 1994) . Low Ca 2 + solutions (-50 nmol/L) were made with 0.5 mmolfL CaCI 2 and 1.2 mmolfL EGTA.
RNA extraction and polymerase chain reaction analysis
At confluence, the cell monolayers were washed with phos phate-buffered saline, and total RNA was isolated by the RNA NOW procedure (Biogentex, Montigny, France). The RNA pel let was extracted by ethanol, dried, dissolved in 10 fLL of water, and RNA concentration was determined by absorbance at 260 nm. Total RNA (100 ng) was reverse-transcribed (50°C for 30 minutes) and amplified using the Titan RT-PCR (Boehringer) system. Polymerase chain reaction conditions were 30 cycles, each consisting of I minute of denaturation at 94°C, 1 minute of hybridization at 57°C, and 2 minutes of elongation at 72°e. The amplified products were separated by 1.2% agarose gel electrophoresis, and the bands were visualized using ethidium bromid. The sequences for sense and antisense primers for the rat PAR-I were 5, ACTATTTCTCCGCCTTCTCCGCCAT 3, corresponding to nucleotides 900-924, and 5, TCACGCAG ACGCAGAGGAGGAGGTAAGC 3, corresponding to nucleo tides I 148-1172 (Zhong et a!., 1992) . The sequences for the rat PAR-2 primers were 5, AACCTGGCCTTGGCAGACCT CCTCTCT 3, corresponding to nucleotides 346-372, and 5, ATGCGTTTCACGGTGCGGACGCTT 3, corresponding to nucleotides 1086-1109 (Saifeddine et a!., 1996) . The sequences for PAR-3 primers: 5, CTTTTCTGTGTCACGCTGCCG 3, and 5, ACAGGTGAGGATGAGAATAGC 3, were from the rat platelet cDNA.
Purification of thrombin and plasminogen
Thrombin was purified from crude bovine thrombin (Sigma, 50 NIHU/mg protein) with ion-exchange chromatography (Lundblad et a!., 1976) ; the specific activity of the thrombin after purification was 1,150 NIHU/mg protein.
Active-site blocked thrombin was prepared by incubating thrombin with 4 mmollL Pefablock (Boehringer) for 30 min utes. Thrombin concentration was determined by active site titration using p-nitrofenilguanidinobenzoate.
Plasminogen was prepared from human plasma by affinity chromatography on Iysine-sepharose (Deutsch and Metz, 1970) . Plasmin was prepared from zymogen by activation with streptokinase; the concentration of the active enzyme was de termined using Spectrozyme-PL (American Diagnostica, New York, U.S.A.).
Statistics Comparison of means was made by using the Stu dent's t test for paired samples.
RESULTS
Identification of brain capillary endothelial cells
Endothelial cells were spindle-shaped and grew in close contact with each other within 5 to 10 days (Fig.  lA) . The endothelial character of these cells was con- firmed by their strong positive granular, perinuclear im munoperoxidase staining for von-Willebrand antigen (Fig. IB) .
Thrombin receptor expression in rat brain
Reverse transcriptase polymerase chain reaction using PAR-I, PAR-2, and PAR-3 primers was performed to detect the presence of thrombin receptors on primary cultures of capillary endothelial cells and astrocytes pre pared from rat brain, as described in Methods above. Rat aortic smooth muscle cells, known to express PARol and PAR-2, were used as a positive control. Primers were designed to rat PARol (Zhong et aI., 1992) , PAR-2 (Saifeddine et aI., 1996) , and PAR-3 sequences, respec tively. Both PARol and PAR-3 thombin receptor mRNA and also PAR-2 mRNA were detected in the cDNA ohat brain capillary endothelial (RBCE) cells, as well as in that of astrocytes (Fig. 2) .
Effect of thrombin on [Ca
2 +]j of rat brain capillary endothelial cells Figure 3 (inset) demonstrates that treatment of RBCE cells with 40 nmollL thrombin (2 NIHU/mL) resulted in a sharp, transient increase of [Ca 2 +J;, reaching a maxi mum within 12 seconds which then gradually declined (within 180 seconds) to baseline. When the same experi ment was performed in a medium containing Ca 2 + in low concentration, the extent of the thrombin-induced in crease in [Ca 2 +]i was reduced, indicating that the rapid changes in [Ca 2 +l were, at least partly, dependent on the presence of extracellular Ca 2 + (data not shown). The ef fect of thrombin on [Ca 2 +]i was concentration-dependent, as demonstrated in Fig. 3 .
The requirement of a cleavage event for the [Ca 2 +l Primers PAR-1 PAR-2 GAPDH PAR-3 Sample St 1 2 3 1 2 3 1 2 3 St 1 2 3 FIG. 2. Expression of proteolytically activated receptor (PAR)-1, PAR-2, and PAR-3 messenger RNA (mRNA) in rat brain capillary endothelial (RBCE) cells. Total cellular RNA was isolated from confluent monolayers of RBCE cells; 100 ng was reverse transcribed and subsequently amplified using proteolytically ac tivated receptor (PAR)-1, PAR-2, PAR-3, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) primers. The molecular size was determined using DNA molecular weight marker VI, and the marker (St) is shown beside sample 1 amplified using PAR-1 and PAR-3 primers. Polymerase chain reaction (PCR) products of PAR-1, PAR-2, PAR-3, and GAPDH mRNA from RBCE cells (sample 1) , from astrocytes of rat forebrain (sample 2) and from rat smooth muscle cells (sample 3), respectively, are shown. rise in response to thrombin in RBCE cells was con firmed by the use of an active-site blocked thrombin which was without an effect (data not shown). Agonist dependent desensitization of the thrombin response was examined by exposing RBCE cells to two consecutive thrombin stimuli. Repeated addition of thrombin (40 nmollL) 300 seconds after the first stimulus induced a very small [Ca 2 +]i signal (Fig. 4) , demonstrating rapid homologous desensitization. Thrombin responsiveness did not increase within the next 2 hours (data not shown), and because cleaved receptors are unable to respond to thrombin this result indicated that new receptors were not expressed in the cells within this period.
Effects of SFLLRN on [Ca 2 +]j
Like thrombin, SFLLRN also elicited a transient in crease in [Ca 2 +l. However, the overall response to SFLLRN was slower and smaller in magnitude as com pared to the increase in [Ca 2 +l induced by thrombin (Fig.  5 ). Peak [Ca 2 +]i rise attributable to 100 f.1mollL SFLLRN was only half of the increase induced by 40 nmollL thrombin. In contrast to the essentially complete desen sitization by thrombin (Fig. 4) , SFLLRN-stimulated cells were still able to respond to a thrombin-stimulus, albeit with an attenuated [Ca 2 +]i signal (Fig. 5) . The magnitude of the [Ca 2 +l increase attributable to thrombin appeared to inversely correlate with the concentration of the first stimulus: cells activated with 100 fLmollL SFLLRN re sponded to thrombin with a smaller [Ca 2 +]j signal com pared to those stimulated with 50 fLmollL agonist peptide (",, 40% and 60% of the response induced by thrombin alone, respectively).
Modification of thrombin responses by plasmin
We have previously shown that plasmin, as well as other fibrinolytic enzymes (urokinase and elastase), pro- voked a contraction of human brain capillary endothelial cells (Nagy et aI., 1995) . In the present study we inves tigated the effect of plasmin on [Ca 2 +]j in RBCE cells. When exposed to plasmin (10 to 400 nmollL) for up to 5 minutes no increase in [Ca 2 +]j was observed (not shown). However, pretreatment of cells with plasmin (100 nmol/ L) almost completely abolished [Ca 2 +L rise in response to thrombin (Fig. 6A ), suggesting that plasmin prevented receptor activation by thrombin. Although plasmin com pletely abolished the activation of RBCE cells by throm bin, it failed to influence the [Ca 2 +L signal induced by ATP, a known purinergic agonist (Fig. 6B ). This indi cates that the effect of plasmin on the thrombin-induced [Ca 2 +]j rise is specific and involves interaction with the thrombin receptor. cells were treated for 60 seconds with plasmin (100 nmoI/L), followed by perfusion with standard buffer. In order to completely remove plasmin, perfusion was stopped at 200 seconds, the con ditioned medium was discarded, and then the perfusion was re started. Thrombin (40 nmol/L) was added at 400 seconds and was present for 60 seconds. The inset shows the change in [Ca 2 +1i after addition of thrombin (10 nmol/L) alone, without pre treatment with plasmin. (8) RBCE cells were treated with plas min, as described in panel A, followed by addition of ATP (100 j.JmoI/L) for 60 seconds. The inset shows the effect of ATP alone. Traces are representative of three experiments.
DISCUSSION
In the present study we demonstrate for the first time the presence of thrombin receptor mRNA and functional thrombin receptors in capillary endothelial cells of the brain (Fig. 2) . One of the receptors identified is PAR-I, which is commonly expressed in platelets (Vu et aI., 1991; Hung et aI., 1992) and large-vessel endothelial cells (Vu et aI., 1991; Hein et aI., 1994) but has not yet been found in brain capillary endothelial cells. Stimula tion of PAR -1 by thrombin resulted in an increase of [Ca 2 +]i in RBCE cells (Fig. 3) . In the presence of a low concentration of extracellular Ca 2 +, the thrombin induced signal was reduced but not abolished, which suggests that both influx of Ca 2 + from the medium and release of Ca 2 + from intracellular pools are involved. In addition to thrombin, the PAR-l agonist peptide SFLLRN also elicited an increase in [Ca 2 +t. Results in Fig. 5 show that SFLLRN diminished but did not com pletely eliminate the subsequent [Ca 2 +]j response to thrombin and that the magnitude of the [Ca 2 +l signal attributable to thrombin was inversely related to the con centration of SFLLRN applied previously. Recent data have shown that, in addition to acting on PAR-I, SFLLRN can activate at least one other receptor: PAR-2, also present on the endothelial cell surface but not acti vated by thrombin (Nystedt et aI., 1995) . Consistent with this, in human umbilical vein endothelial cells, [Ca 2 +L response to SFLLRN is larger than that induced by thrombin (Molino et aI., 1997) . Although we show that RBCE cells as human umbilical vein endothelial cells express PAR-2 (Fig. 2) , the persistently higher [Ca 2 +]j signal induced by thrombin as compared to that elicited by SFLLRN suggests the coexistence of another throm bin receptor in RBCE cells which could not be activated by the PAR-l agonist peptide. Indeed, this paper dem onstrates the presence of PAR-3 mRNA in RBCE cells, which could contribute to the [Ca 2 +t rise in response to thrombin but not to SFLLRN. As with endothelial cells, astrocytes derived from rat forebrain also expressed PAR-3, in addition to PAR-I and PAR-2 (Fig. 2) . Thrombin has been reported to reverse the [3-amyloid induced stellate morphology in astrocytes, and this effect has been mimicked by the PAR-l agonist peptide (Pike et aI., 1996) . In contrast, thrombin potentiates rather than attenuates the [3-amyloid-induced b-FGF secretion (Pike et aI., 1996) , suggesting that it differentially modulates the effects of [3-amyloid in astrocytes and that the effects might be mediated through different thrombin receptors.
According to earlier findings, PAR-l becomes quickly desensitized after activation by thrombin (Brass, 1992; Ishii et aI., 1994) . This is thought to be attributable to two events: phosphorylation of sites in the cytoplasmic do mains of the receptor and cleavage of the receptor N terminus (Ishii et aI., 1994) . However, numerous studies J Cereb Blood Flow Metab, Vol. 20, No. I, 2000
addressing PAR-l regulation by thrombin indicate that it is highly variable and cell type-specific (Weinstein et aI., 1998) . In platelets and megakaryoblastic cell lines, re ceptor cleavage is followed by rapid internalization with a full recovery of the thrombin responsiveness occurring over a long time period (Hein et aI., 1994) . In contrast, in endothelial cells and in fibroblasts, an intracellular pool of intact receptors rapidly replaces the cleaved receptors and allows cells to respond to the next stimulus (Hein et aI., 1994) . In neuronal cells, PAR-l regulation by throm bin resembles that observed in megakaryocytes (Wein stein et aI., 1998) . Here we report that RBCE cells also became refractory to a second stimulation by thrombin ( Fig. 4) and no recovery of the thrombin responsiveness was observed for at least 2 hours. These observations indicate that RBCE cells do not restore intact thrombin receptors at a rate comparable to that in human umbilical vein endothelial cells; the pattern of slow receptor recov ery was similar to that reported for platelets, megakaryo blasts, and neurons. Conversely, when RBCE cells were initially activated by a high concentration of SFLLRN, they showed a diminished but still measurable response to thrombin (Fig. 5) , even when the peptide was not washed out from the incubation medium. This observa tion is again markedly different from that made in human umbilical vein endothelial cells, where PAR-l was de sensitized after receptor activation by either thrombin or SFLLRN. Because PAR-3 is not activated by SFLLRN, this result could be explained by the coexpression of PAR-l and PAR-3 receptors on RBCE cells. The desen sitization of PAR -3 by thrombin has not yet been studied, but it may be different from that of PAR-1.
The experiments on a possible effect of plasmin on [Ca 2 +]i in RBCE cells were motivated by our previous observation that nanomolar concentrations of plasmin caused contractions in cultured human brain capillary endothelial cells (Nagy et aI., 1995) , and by the fact that thrombin receptor was cleaved by plasmin at Arg 41 _Ser 42 (Parry et aI., 1996) . We found that plasmin itself did not cause any increase in [Ca 2 +l, indicating that plasmin induced contraction in endothelial cells might be attrib utable to a Ca 2 +-independent mechanism. In addition, plasmin was able to abolish the thrombin-induced in crease in [Ca 2 +]j (Fig. 6 ). This is in agreement with re sults obtained in platelets (Kimura et aI., 1996) and C6 glioma cells (Turner et a!., 1994) , where low doses of plasmin inhibited thrombin-induced responses. Probably plasmin, besides cleaving PAR-l at Arg 41 _Ser 42 , also cleaves the receptor at a site closer to the C terminus resulting in the loss of the tethered ligand, as has been shown for cathepsin G (Molino et aI., 1995) . As yet there are no data on the cleavage of PAR-3 by plasmin. Our data showing that plasmin completely abolishes the thrombin-induced increase in [Ca 2 +]j in RBCE cells, where both PAR-l and PAR-3 are present, would sug-gest that plasmin also inactivates PAR-3, but further ex periments are needed to prove this.
Reverse transcriptase-polymerase chain reaction analysis in our experiments also showed the presence of PAR-2 in RBCE cells and in astrocytes. PAR-2 is known to be activated by trypsin, or mast cell tryptase; however, the native physiologic activator and the cellular function of PAR -2 remain unknown. A recent study has provided evidence that PAR -2 is also present in the brain, and as is the case with PAR-I, it may play a role in neurode generation (Smith-Swintosky et aI., 1997) . Our results, showing the presence of PAR-2 mRNA in primary cul tures of astrocytes and capillary endothelial cells from rat brain, support these data and also suggest a role for PAR-2 in the brain.
In conclusion, PAR-I mRNA is expressed in RBCE cells, and stimulation of PAR -1 receptors by thrombin and by SFLLRN mediates an increase in [Ca 2 +L-How ever, another thrombin receptor, PAR-3, is also ex pressed and might contribute to the thrombin-induced increase in [Ca 2 +l. The susceptibility of the receptor(s) to proteolysis by plasmin may play a role in the response of the endothelial cell to thrombin, when fibrinolysis occurs parallel with blood coagulation. Besides playing a principal role in hemostasis, thrombin may be an impor tant regulator in neuronal development and may contrib ute to brain injury in certain pathologic situations. The identification of PAR-l and PAR-3 in endothelial cells and astrocytes may help to elucidate the role and impor tance of distinct thrombin receptors in the brain.
